Texas 2023 88th Regular

Texas House Bill HB2529 Fiscal Note / Fiscal Note

Filed 04/27/2023

                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION             April 27, 2023       TO: Honorable Stephanie Klick, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB2529 by Talarico (Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.), As Introduced     No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources.  Local Government ImpactNo fiscal implication to units of local government is anticipated.  Source Agencies: b > td > 529 Health and Human Services Commission, 537 State Health Services, Department of  LBB Staff: b > td > JMc, NPe, ER, CST

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
April 27, 2023

 

 

  TO: Honorable Stephanie Klick, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB2529 by Talarico (Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.), As Introduced   

TO: Honorable Stephanie Klick, Chair, House Committee on Public Health
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB2529 by Talarico (Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.), As Introduced

 Honorable Stephanie Klick, Chair, House Committee on Public Health

 Honorable Stephanie Klick, Chair, House Committee on Public Health

 Jerry McGinty, Director, Legislative Budget Board 

 Jerry McGinty, Director, Legislative Budget Board 

 HB2529 by Talarico (Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.), As Introduced 

 HB2529 by Talarico (Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.), As Introduced 



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.

It is assumed that any costs associated with the bill could be absorbed using existing resources.

 Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 529 Health and Human Services Commission, 537 State Health Services, Department of

529 Health and Human Services Commission, 537 State Health Services, Department of

LBB Staff: b > td > JMc, NPe, ER, CST

JMc, NPe, ER, CST